Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

General Director of PIK became Yervand Karapetyan

4/2/24 PIKK

Samaraenergo reported for 2023 by RAS

4/2/24 SAGO

Fesco reports for 2023 by RAS

4/2/24 FESH

Pyatyorochka has entered Yakutia

4/2/24 X5

EL5-Energo reported for 2023 by IFRS

4/2/24 ELFV

Astra reported for 2023 by IFRS

4/2/24 ASTR

Zaimer officially announced its intention to conduct an IPO

4/2/24 ZAYM

Novatek sharply reduced gas production at Arctic LNG-2

4/2/24 NVTK

Sollers reported for 2023 by RAS

4/2/24 SVAV

RBC reports for 2023 according by RAS

4/1/24 RBCM